Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for Transition products commencing 1 May 2024<br/>Offer reference number: CM/TNS/05/2024<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/05/2024/01<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)<br/><br/>CM/TNS/05/2024/02<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Aspire Pharma Limited | 06828501 | ~£137,997,000 estimated from lot values | 1 lot CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin | - |
| Celix Pharma Ltd. | 12474195 | ~£137,997,000 estimated from lot values | 1 lot CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£137,997,000 estimated from lot values | 1 lot CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin | - |
| Glenmark Pharmaceuticals Europe Limited | 05040260 | ~£41,395,000 estimated from lot values | 1 lot CM/TNS/05/2024/02 - Apixaban, Sapropterin | - |
| Immedica Pharma AB | - | ~£137,997,000 estimated from lot values | 1 lot CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin | - |
| Kent Pharma Ltd | - | ~£137,997,000 estimated from lot values | 1 lot CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin | - |
| LogixX Pharma Ltd | 07209211 | ~£41,395,000 estimated from lot values | 1 lot CM/TNS/05/2024/02 - Apixaban, Sapropterin | - |
| Mylan | 05460854 | ~£179,392,000 estimated from lot values | 2 lots CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin · CM/TNS/05/2024/02 - Apixaban, Sapropterin | - |
| Sandoz Ltd | 01547204 | ~£137,997,000 estimated from lot values | 1 lot CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin | - |
| Selective Supplies Ltd. | 03794482 | ~£41,395,000 estimated from lot values | 1 lot CM/TNS/05/2024/02 - Apixaban, Sapropterin | - |
| Teva UK Limited | 00302461 | ~£41,395,000 estimated from lot values | 1 lot CM/TNS/05/2024/02 - Apixaban, Sapropterin | - |
| Thornton and Ross Ltd | 00185947 | ~£179,392,000 estimated from lot values | 2 lots CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin · CM/TNS/05/2024/02 - Apixaban, Sapropterin | - |
This procurement was divided into 2 lots, each awarded separately. 182 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin May 2024 – Sept 2025 | £137,997,000 £8 initial term | 16 | Kent Pharma Ltd Celix Pharma Ltd. Dr.Reddy's Laboratories (UK) Limited Thornton and Ross Ltd Mylan Sandoz Ltd Immedica Pharma AB Aspire Pharma Limited | active |
| Lot 2 CM/TNS/05/2024/02 - Apixaban, Sapropterin May 2024 – Sept 2024 | £41,395,000 £6 initial term | 9 | Teva UK Limited Thornton and Ross Ltd Glenmark Pharmaceuticals Europe Limited Mylan Selective Supplies Ltd. LogixX Pharma Ltd | active |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £100,254,393 in 204 payments (over £25k) from Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT, Maidstone and Tunbridge Wells NHS Trust, BEIS (2010-07-22 to 2026-03-12).
Published by the buyer on this notice. Check the original notice — details change and are not updated here.